NVCT
Nuvectis PharmaยทNASDAQ
--
--(--)
--
--(--)
NVCT fundamentals
Nuvectis Pharma (NVCT) released its earnings on Aug 5, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -0.3 (YoY -15.38%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.3
-15.38%
Report date
Aug 5, 2025
Earnings Call
9:00 AM on Aug 5, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Nuvectis Pharma (NVCT) key financial stats and ratios, covering profitability, financial health, and leverage.
Nuvectis Pharma (NVCT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nuvectis Pharma (NVCT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nuvectis Pharma (NVCT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nuvectis Pharma (NVCT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nuvectis Pharma (NVCT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Nuvectis Pharma's management provide for the next earnings period?What does Nuvectis Pharma do and what are its main business segments?What factors drove the changes in Nuvectis Pharma's revenue and profit?What is the revenue and EPS growth rate for Nuvectis Pharma year over year?What were the key takeaways from Nuvectis Pharma's earnings call?What is Nuvectis Pharma's gross profit margin?What is Nuvectis Pharma's latest dividend and current dividend yield?What is the market's earnings forecast for Nuvectis Pharma next quarter?
